Severity
Moderate
FDA Drug recall · Reported February 19, 2020
Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.
Akorn Inc recalled Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx only, HI-TECH… - a moderate-severity action.
Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx only, HI-TECH… was recalled by Akorn Inc in February 19, 2020. Reason: Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.. Check the official notice for the remedy. Verify recall #D-0839-2020 with the FDA Drug before acting.
The recall
Akorn Inc issued this moderate-severity FDA Drug recall-Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product..
Sourced from official FDA Drug enforcement records. Verify recall #D-0839-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0839-2020) was formally reported on February 19, 2020, with the manufacturer initiating the action on December 16, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Akorn Inc is listed as the recalling firm, operating out of Lake Forest, IL. Federal records list the affected scope as 16,078 bottles.
The documented reason for this recall is: Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product. Distribution data in the federal record shows the product reached: Nationwide in the USA and Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
16,078 bottles
Related Recalls
6
5 from same agency
Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL dropper bottle, Rx only, HI-TECH PHARMACAL CO., INC., Amityville, NY 11701; NDC 50383-901-10.
Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0839-2020 |
| Date reported | February 19, 2020 |
| Date initiated | December 16, 2019 |
| Recalling firm | Akorn Inc |
| Firm location | Lake Forest, IL |
| Affected scope | 16,078 bottles |
| Distribution | Nationwide in the USA and Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 19, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.